You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 267 No. 1, January 1, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentaries
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Childhood Cholesterol Screening: Contraindicated

Thomas B. Newman, MD, MPH; Warren S. Browner, MD, MPH; Stephen B. Hulley, MD, MPH

JAMA. 1992;267(1):100-101.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WE RECENTLY presented the case against childhood cholesterol screening.1 In short, screening children, even the 25% with a family history of high blood cholesterol or early coronary artery disease, is a waste of money that is likely to do more harm than good. Resnicow et al,2 in "The Case Against `the Case Against Childhood Cholesterol Screening,'" disagree with our position. They make three important points we wish to reiterate: (1) "Extrapolation of findings from... nonrepresentative adult populations to the general pediatric population should be made with extreme caution." (2) "There are many empirical questions regarding the efficacy and safety of early (universal) detection and treatment of hypercholesterolemia in children that can only be answered through controlled research." (3) "Any discussion regarding the early detection and treatment of hypercholesterolemia should be framed by the parameters of whether the ultimate gains, both medical and economic, outweigh the risks."

Given their . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Pediatrics (Dr Newman), Medicine (Drs Browner and Hulley), and Epidemiology and Biostatistics (Drs Newman, Browner, and Hulley) and the Robert Wood Johnson Clinical Scholars Program (Drs Newman and Browner), School of Medicine, University of California at San Francisco.


Footnotes

Reprint requests to Division of General Pediatrics, Box 0314, University of California at San Francisco, San Francisco, CA 94143 (Dr Newman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.